Find information on thousands of medical conditions and prescription drugs.

Doxazosin

Doxazosin mesylate, a quinazoline compound sold by Pfizer under the brand name Cardura, is an alpha blocker used to treat high blood pressure and benign prostatic hyperplasia. It works by blocking the action of adrenaline on smooth muscle of the bladder and the blood vessel walls.

Its empirical formula is C₂₃H₂₅N₅O₅•CH₄O₃S, and it has a molecular weight of 547.6.

A

B

C

D

Dextromethorphan

Dextropropoxyphene

Diethylcarbamazine

Diethylstilbestrol

Diethyltoluamide

Dihydroergotamine

Dihydrotachysterol

Dimethyl sulfoxide

Dimethyltryptamine

Diphenhydramine

Docusate sodium

Dv

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Read more at Wikipedia.org

• [List your site here Free!]


		Drug combo tackles prostatic hyperplasia: finasteride, doxazosin.(Clinical Rounds) : An article from: Family Practice News $5.95			Help for metabolic syndrome in Asian Indians.(Diabetes) : An article from: Family Practice News $5.95

		FDA Panel Says ALLHAT Findings On Doxazosin Should Be Issued.(Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial finds that doxazosin ... : An article from: Internal Medicine News $5.95


	Hypertension: Doxazosin or Chlorthalidone? The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) was conducted to determine whether chlorthalidone or three other antihypertensives had differing effects on From American Family Physician, 10/15/00 by Grace Brooke Huffman

	How effective is doxazosin compared with chlorthalidone in the treatment of hypertension? The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomized to ... From Journal of Family Practice, 7/1/00 by Peter G. Koval

	Doxazosin Linked to Congestive Heart Failure, Stroke - Brief Article ANAHEIM, CALIF. -- The a-blocker arm of a landmark megatrial of antihypertensive therapy has been halted early due to sharp increases in congestive heart failure and stroke. The National Heart, L From Family Pratice News, 4/15/00 by Bruce Jancin

	Teva, Apotex gain approval for doxazosin - Brief Article Teva and Apotex separately have received Food and Drug Administration approval to market doxazosin mesylate in 1 mg, 2 mg, 4 mg and 8 mg strengths. Doxazosin ... From Drug Store News, 12/18/00

	Four strengths of doxazosin approved - Brief Article Ivax, Purepac and KY Pharmaceutical Co. all received FDA approval to market doxazosin mesylate in 1 mg, 2 mg, 4 mg and 8 mg strengths. Doxazosin mesylate ... From Drug Store News, 11/27/00

	Doxazosin Not First-line Drug for Hypertension The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group: Major cardiovascular events in hypertensive patients randomized to doxazosin ... From Nurse Practitioner, 9/1/00 by Risser, Nancy

	Ivax receives tentative approval for doxazosin mesylate tablets - Brief Article - Statistical Data Included The FDA has given tentative approval for Ivax Corp.'s ANDA for doxazosin mesylate in 1 mg., 2 mg., 4 mg. and 8 mg. tablet strengths. Indicated for ... From Drug Store News, 8/28/00

	[beta]-blockers with vasodilatory actions - communications to the editor To the Editor: We have read with interest the article by Dart et al (January 2003) (1) and would like to make few comments. The authors have grouped ... From CHEST, 10/1/03

Home

Contact

Resources

ebay